STAT3 is a key transcription factor mediating inflammatory and immune responses [35], and while inhibition of STAT3 within tumor cells may be clinically beneficial, blocking STAT3-mediated immunity may negate this effect. The gene discussed is STAT3; the disease is neoplasm.